These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Nakamura T, Seto M, Tajika M, Kawai H, Yokoi T, Yatabe Y, Nakamura S. Am J Gastroenterol; 2008 Jan; 103(1):62-70. PubMed ID: 17894851 [Abstract] [Full Text] [Related]
3. Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series. Fischbach W, Goebeler ME, Ruskone-Fourmestraux A, Wündisch T, Neubauer A, Raderer M, Savio A, EGILS (European Gastro-Intestinal Lymphoma Study) Group. Gut; 2007 Dec; 56(12):1685-7. PubMed ID: 17639089 [Abstract] [Full Text] [Related]
4. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, Wang HP, Kuo SH, Sheu BS, Jan CM, Wang WM, Wang TE, Wu CW, Chen CL, Su IJ, Whang-Peng J, Cheng AL. J Natl Cancer Inst; 2005 Sep 21; 97(18):1345-53. PubMed ID: 16174856 [Abstract] [Full Text] [Related]
6. Treatment of low grade gastric mucosa-associated lymphoid tissue lymphoma in stage I with Helicobacter pylori eradication. Long-term results after sequential histologic and molecular follow-up. Montalban C, Santon A, Boixeda D, Redondo C, Alvarez I, Calleja JL, de Argila CM, Bellas C. Haematologica; 2001 Jun 21; 86(6):609-17. PubMed ID: 11418369 [Abstract] [Full Text] [Related]
7. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Nakamura S, Matsumoto T, Suekane H, Nakamura S, Matsumoto H, Esaki M, Yao T, Iida M. Cancer; 2005 Aug 01; 104(3):532-40. PubMed ID: 15937928 [Abstract] [Full Text] [Related]
9. Patients with Helicobacter pylori negative gastric marginal zone b-cell lymphoma (MZBCL) of MALT have a good prognosis. Al-Taie O, Al-Taie E, Fischbach W. Z Gastroenterol; 2014 Dec 01; 52(12):1389-93. PubMed ID: 25474277 [Abstract] [Full Text] [Related]
10. Characteristics of Helicobacter pylori-positive and Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphoma and their influence on clinical outcome. Choi YJ, Kim N, Paik JH, Kim JM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC. Helicobacter; 2013 Jun 01; 18(3):197-205. PubMed ID: 23305046 [Abstract] [Full Text] [Related]
12. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Hong SS, Jung HY, Choi KD, Song HJ, Lee GH, Oh TH, Jo JY, Kim KJ, Byeon JS, Myung SJ, Yang SK, Hong WS, Kim JH, Min YI. Helicobacter; 2006 Dec 01; 11(6):569-73. PubMed ID: 17083379 [Abstract] [Full Text] [Related]
13. Regression of primary gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma after eradication of Helicobacter pylori. Falcó Jover G, Martínez Egea A, Sánchez Cuenca J, Onrubia Pintado J, García Lafuente N, Ruiz Gómez F, Coronas Planas M. Rev Esp Enferm Dig; 1999 Aug 01; 91(8):541-8. PubMed ID: 10491486 [Abstract] [Full Text] [Related]
14. Patients with gastric MALT lymphoma revealing persisting endoscopic abnormalities after successful eradication of Helicobacter pylori can be safely managed by a watch-and-wait strategy. Fischbach W, Dorlöchter C. Z Gastroenterol; 2019 May 01; 57(5):593-599. PubMed ID: 31083747 [Abstract] [Full Text] [Related]
15. Translocation t(11;18)(q21;q21) is not predictive of response to chemotherapy with 2CdA in patients with gastric MALT lymphoma. Streubel B, Ye H, Du MQ, Isaacson PG, Chott A, Raderer M. Oncology; 2004 May 01; 66(6):476-80. PubMed ID: 15452377 [Abstract] [Full Text] [Related]
16. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. Wündisch T, Thiede C, Morgner A, Dempfle A, Günther A, Liu H, Ye H, Du MQ, Kim TD, Bayerdörffer E, Stolte M, Neubauer A. J Clin Oncol; 2005 Nov 01; 23(31):8018-24. PubMed ID: 16204012 [Abstract] [Full Text] [Related]
17. Gastric mucosal-associated lymphoid tissue lymphoma. Fischbach W. Gastroenterol Clin North Am; 2013 Jun 01; 42(2):371-80. PubMed ID: 23639646 [Abstract] [Full Text] [Related]
18. [Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication. Follow-up of the histological and molecular response]. Montalbán C, Manzanal A, Boixeda D, Redondo C, Alvarez I, Frutos B, Calleja JL, Sánchez-Godoy P, Bellas C. Med Clin (Barc); 1998 Jan 24; 110(2):41-4. PubMed ID: 9534129 [Abstract] [Full Text] [Related]
19. Treatment of gastric MALT lymphoma by Helicobacter pylori eradication: a study controlled by endoscopic ultrasonography. Nobre-Leitão C, Lage P, Cravo M, Cabeçadas J, Chaves P, Alberto-Santos A, Correia J, Soares J, Costa-Mira F. Am J Gastroenterol; 1998 May 24; 93(5):732-6. PubMed ID: 9625118 [Abstract] [Full Text] [Related]
20. Long-term follow-up of gastric lymphoma after stomach conserving treatment. Fischbach W. Best Pract Res Clin Gastroenterol; 2010 Feb 24; 24(1):71-7. PubMed ID: 20206110 [Abstract] [Full Text] [Related] Page: [Next] [New Search]